Neurodiagnostics Evolved
Improving Outcomes with Advanced Detection
Meet MindRhythm
MindRhythm is a medical technology company focused on improving outcomes caused by neurological injury. Founded by world-renowned scientific experts with significant commercialization success, MindRhythm’s detection and monitoring platform technology provides real-time visibility to life-threatening situations at home, in an EMS setting, on the battlefield, on the athletic field, during surgery, and in the ICU.
MindRhythm’s technology allows clinicians to intervene, optimize, and manage care to prevent brain damage. Collaborating with the healthcare community, MindRhythm is actively testing application of a systematic approach to reduce time to treatment in strokes, accurate recovery determination in concussion, and prevention of primary and secondary injury in a variety of neurological conditions.
Stroke
With 800,000 strokes occurring each year, stroke is the 5th leading cause of death. This death toll can be partly attributed to the fact that there is no way to objectively diagnose between stroke types especially in the prehospital space wherein the care continuum begins resulting in confusion of treatment needs between a patient who is experiencing a Large Vessel Occlusion (LVO) versus a Small Vessel stroke.
This confusion often leads to misdiagnosis, and ineffective triage to a hospital that may not have the necessary treatment capabilities as most hospitals do not have the technology to treat LVOs. Sending patients to the wrong hospital can have catastrophic patient results and negative financial impact to the patient and system.
Concussion
69 million suspected concussions occur globally with approximately 4 million of those occurring in the United States alone. A significant portion of these concussions are a result of recreational, student, or professional sports injuries wherein 40 percent of those athletes return to play prematurely. Due to the lack of proper diagnostic tools, it is believed that concussions in the US are perhaps double the statistical average due to underreporting. Concussion is considered a mild traumatic brain injury but is not a benign disease, it leads to debilitating conditions when not properly managed.
Without proper monitoring of recovery from concussion, these victims are at risk for significant neurological damage. A second concussion that occurs while the brain is in recovery mode has significant deleterious effects to the sufferer, often resulting in permanent neurological disability, or in certain cases, death.
The MindRhythm Cranial Accelogram
MindRhythm developed a novel, noninvasive, diagnostic, disposal medical device that produces a unique biomarker with multiple clinical applications. Today, the device is designed to rapidly identify patients with Large Vessel Occlusion (LVO) strokes and monitor recovery from concussion via detection of a specific physiology discovered by MindRhythm. LVO stroke patients will benefit from rapid transport to a Comprehensive Stroke Center (CSC) that has the physicians, technologists and equipment needed to remove the clot.
In patients with concussion, MindRhythm’s systematic approach to timely detection, monitoring, and management will promote a safe recovery from impact. Concussion is an independent risk factor for stroke, CTE, Alzheimer's, depression, and more, meaning that improving concussive management and return decisions early with the MindRhythm device could prevent future strokes and other debilitating neurological conditions.
MindRhythm’s finely tuned proprietary technology and communication platform effectively triages patients, monitors recovery, and communicates patient data, to ready treatment teams to optimize patient treatment and outcomes.
Improving Outcomes
Saving Lives
